CLPBY
Coloplast A/S
Set alert
- YTD
- -14.82%
- 1 year
- -20.61%
- Open
- 7.32
- Prev close
- 7.20
- Mkt cap
- 16.32B
- Vol
- 6.28K
- Avg vol
- 205.17K
- EPS
- 0.19
- P/E
- 38.11
More statistics
- Low
- 7.24
- High
- 7.32
- Earnings
- Aug 18, 2026
News
2 weeks ago defenseworld.net
Coloplast A/S (OTCMKTS:CLPBY) Shares Climb 3.9% – Should You Buy?
Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY - Get Free Report) were up 3.9% during trading on Monday. The company traded as high as $6.72 and last traded at $6.71. Approximately 24,521…
2 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q3 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q3 2026 Earnings Call Transcript
2 months ago reuters.com
Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says
Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall…
2 months ago seekingalpha.com
Coloplast Might Have Found Its Bottom
Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion…
5 months ago seekingalpha.com
Coloplast: Went 'BUY' A Bit Early
Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls,…
5 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
6 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q4 2026 Guidance Call Transcript
Coloplast A/S (CLPBY) Q4 2026 Guidance Call Transcript
7 months ago defenseworld.net
Comparing Coloplast A/S (OTCMKTS:CLPBY) & Bluejay Diagnostics (NASDAQ:BJDX)
Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two…
7 months ago seekingalpha.com
Coloplast: The Market Is Throwing Away A High-Quality Compounder
Coloplast is now a clear Buy, trading nearly 60% below its all-time high and at historically low valuation multiples. CLPBF's wide economic moat, underpinned by patents and high switching costs,…
7 months ago globenewswire.com
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
7 months ago globenewswire.com
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
8 months ago globenewswire.com
Coloplast appoints Gavin Wood as new CEO
Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and…
8 months ago zacks.com
CLPBY or PEN: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a…
8 months ago defenseworld.net
Reviewing OPKO Health (NASDAQ:OPK) and Coloplast A/S (OTCMKTS:CLPBY)
Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based…
8 months ago globenewswire.com
Coloplast A/S - Updated Financial Calendar 2025-26
Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General…
8 months ago defenseworld.net
Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Down – What’s Next?
Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY - Get Free Report)'s share price gapped down prior to trading on Friday. The stock had previously closed at $8.38, but opened at $7.83. Coloplast A/S shares…
8 months ago seekingalpha.com
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
8 months ago globenewswire.com
Coloplast A/S - Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…
-
8 months ago globenewswire.com
Coloplast A/S - Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…
9 months ago zacks.com
CLPBY vs. PEN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Stocks That Hit 52-Week Highs On Monday